1. Home
  2. SFM vs GKOS Comparison

SFM vs GKOS Comparison

Compare SFM & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprouts Farmers Market Inc.

SFM

Sprouts Farmers Market Inc.

HOLD

Current Price

$76.13

Market Cap

6.9B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$118.86

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFM
GKOS
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.0B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
SFM
GKOS
Price
$76.13
$118.86
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
$98.89
$133.07
AVG Volume (30 Days)
2.0M
652.5K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
41.60
N/A
EPS
5.31
N/A
Revenue
$8,806,159,000.00
$507,442,000.00
Revenue This Year
$9.05
$23.30
Revenue Next Year
$7.46
$27.43
P/E Ratio
$14.52
N/A
Revenue Growth
14.08
32.33
52 Week Low
$64.75
$73.16
52 Week High
$182.00
$130.23

Technical Indicators

Market Signals
Indicator
SFM
GKOS
Relative Strength Index (RSI) 47.70 60.81
Support Level $75.26 $104.72
Resistance Level $82.28 $123.16
Average True Range (ATR) 2.51 4.51
MACD -0.39 1.61
Stochastic Oscillator 41.88 80.37

Price Performance

Historical Comparison
SFM
GKOS

About SFM Sprouts Farmers Market Inc.

Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: